EyePoint Pharmaceuticals (EYPT) Insider Trading & Ownership $7.10 -0.02 (-0.28%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EyePoint Pharmaceuticals (NASDAQ:EYPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.74%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$37.64 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$39.34 M Get EYPT Insider Trade Alerts Want to know when executives and insiders are buying or selling EyePoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EYPT Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin EyePoint Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/20/2024Wendy F DiciccoDirectorBuy2,567$7.79$19,996.93 7/12/2024David R GuyerDirectorSell11,625$10.06$116,947.50 5/14/2024David R GuyerDirectorSell11,625$12.65$147,056.25 5/6/2024Cormorant Asset Management, LpMajor ShareholderBuy850,000$11.86$10,081,000.00 4/18/2024Cormorant Asset Management, LpMajor ShareholderBuy581,765$18.03$10,489,222.95 2/2/2024David Scott JonesSVPSell209$28.49$5,954.41 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/26/2024Dario A PaggiarinoInsiderSell49,325$25.66$1,265,679.50 1/25/2024David Scott JonesSVPSell600$25.00$15,000.00 1/23/2024Dario A PaggiarinoInsiderSell5,135$25.00$128,375.00 1/23/2024David Scott JonesSVPSell900$25.00$22,500.00 1/11/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.75$14,812,500.00 1/11/2024Ye LiuDirectorSell1,910,500$19.45$37,159,225.00 1/9/2024Cormorant Asset Management, LpMajor ShareholderBuy105,000$21.32$2,238,600.00 1/8/2024Dario A PaggiarinoInsiderSell22,913$21.13$484,151.69 (Data available from 1/1/2013 forward) EYPT Insider Trading Activity - Frequently Asked Questions Who is on EyePoint Pharmaceuticals's Insider Roster? The list of insiders at EyePoint Pharmaceuticals includes Cormorant Asset Management, Lp, Dario A Paggiarino, David R Guyer, David Scott Jones, Ew Healthcare Partners, L.P., Michael Craig Pine, Wendy F Dicicco, and Ye Liu. Learn more on insiders at EYPT. What percentage of EyePoint Pharmaceuticals stock is owned by insiders? 4.74% of EyePoint Pharmaceuticals stock is owned by insiders. Learn more on EYPT's insider holdings. Which EyePoint Pharmaceuticals insiders have been buying company stock? The following insiders have purchased EYPT shares in the last 24 months: Cormorant Asset Management, Lp ($89,495,141.69), and Wendy F Dicicco ($19,996.93). How much insider buying is happening at EyePoint Pharmaceuticals? Insiders have purchased a total of 4,796,624 EYPT shares in the last 24 months for a total of $89,515,138.62 bought. Which EyePoint Pharmaceuticals insiders have been selling company stock? The following insiders have sold EYPT shares in the last 24 months: Dario A Paggiarino ($1,907,366.19), David R Guyer ($264,003.75), David Scott Jones ($43,454.41), Ew Healthcare Partners, L.P. ($4,296,673.06), Michael Craig Pine ($990,000.00), and Ye Liu ($42,060,746.22). How much insider selling is happening at EyePoint Pharmaceuticals? Insiders have sold a total of 2,653,425 EyePoint Pharmaceuticals shares in the last 24 months for a total of $49,562,243.63 sold. EyePoint Pharmaceuticals Key ExecutivesDr. Jay S. Duker M.D. (Age 65)President, CEO & Director Compensation: $848.5kDr. John B. Landis M.S. (Age 71)Ph.D., Interim Head of R&D and Director Compensation: $63.75kMr. Michael Pine (Age 47)Chief Business Officer Compensation: $764.85kMr. George O. Elston (Age 59)Executive VP & CFO Compensation: $743.86kMr. Michael J. MaciocioSenior Vice President of Manufacturing & OperationsMr. Ron I. Honig Esq.Chief Legal Officer & Company SecretaryMs. Jennifer LeonardChief People Officer & Senior VP of ITMr. David Scott Jones (Age 56)Senior VP & Chief Commercial Officer Compensation: $672.08kMs. Isabelle LefebvreChief Regulatory OfficerDr. Marcia Sellos-Moura Ph.D.Senior Vice President of Program Leadership More Insider Trading Tools from MarketBeat Related Companies TRNS Insider Trades CTKB Insider Trades LAB Insider Trades AEHR Insider Trades QTRX Insider Trades SENS Insider Trades NAUT Insider Trades QSI Insider Trades FEIM Insider Trades KEQU Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:EYPT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EyePoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EYPT Stock Alerts